Therapeutics: Mastermind like transcriptional coactivator 1 (MAML1); Notch 1 (NOTCH1)

Cancer

INDICATION: Cancer

In vitro, cell and zebrafish studies identified a thiazolidinedione-based MAML1 inhibitor that could

Read the full 148 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE